FibroGen (FGEN) News Today $0.62 0.00 (0.00%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$0.59▼$0.6550-Day Range$0.38▼$0.8152-Week Range$0.33▼$25.69Volume774,248 shsAverage Volume1.88 million shsMarket Capitalization$60.97 millionP/E RatioN/ADividend YieldN/APrice Target$22.00 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meetingfinance.yahoo.com - December 9 at 5:54 PMFibroGen (NASDAQ:FGEN) Coverage Initiated at StockNews.comamericanbankingnews.com - December 8 at 1:20 AMFibroGen, Inc. (FGEN) stock price, news, quote & history – Yahoo Financesg.finance.yahoo.com - December 4 at 9:31 AMFibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Recommendation of "Reduce" from Analystsamericanbankingnews.com - November 30 at 2:16 AMFibroGen (NASDAQ:FGEN) Now Covered by StockNews.comamericanbankingnews.com - November 30 at 1:30 AMFibroGen Inc FGENmorningstar.com - November 11 at 3:35 PMFibroGen, Inc. (NASDAQ:FGEN) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 7 at 3:51 PMFibroGen (FGEN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimatesfinance.yahoo.com - November 6 at 9:43 PMFibroGen Inc (FGEN) Reports 155% YoY Increase in Q3 2023 Net Revenuefinance.yahoo.com - November 6 at 9:43 PMFibroGen Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 6 at 4:43 PMFibroGen earnings: here's what Wall Street expectsmarkets.businessinsider.com - November 5 at 10:41 AMBronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Fibrogen, Inc. (FGEN) Investigationbarrons.com - October 29 at 2:05 PMFibroGen to Report Third Quarter 2023 Financial Resultsfinance.yahoo.com - October 23 at 9:28 AMFibroGen's Pamrevlumab Doesn't Meet Goals In Phase III LELANTOS-2 Trial; Stock Down In Pre-marketmarkets.businessinsider.com - August 30 at 11:15 AMThree In A Row: FibroGen's Investigational Drug Flunks In Another Study For Rare Disease In Young Boysmarkets.businessinsider.com - August 30 at 11:15 AMFibroGen stock plummets as muscular dystrophy drug trial failsproactiveinvestors.com - August 30 at 11:15 AMFibroGen (NASDAQ: FGEN) Tumbles after Setback in Phase 3 DMD Trialmsn.com - August 30 at 11:15 AMStocks to Watch: FibroGen, Boxmarketwatch.com - August 29 at 11:12 PMFibroGen's drug misses mark on yet another clinical trialfinance.yahoo.com - August 29 at 11:12 PMFibroGen Shares Sink 16% on Pamrevlumab Study Not Meeting Primary Endpointmarketwatch.com - August 29 at 6:11 PMFibroGen stock tumbles on failed Phase 3 study for muscular dystrophy drugmsn.com - August 29 at 6:11 PMFibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophyfinance.yahoo.com - August 29 at 6:11 PMFibroGen, Inc. (NASDAQ:FGEN) Receives Consensus Rating of "Reduce" from Analystsmarketbeat.com - August 22 at 4:37 AMDown -46.88% in 4 Weeks, Here's Why FibroGen (FGEN) Looks Ripe for a Turnaroundfinance.yahoo.com - August 16 at 5:06 PMQ3 2023 Earnings Forecast for FibroGen, Inc. Issued By William Blair (NASDAQ:FGEN)marketbeat.com - August 10 at 7:44 AMIs There An Opportunity With FibroGen, Inc.'s (NASDAQ:FGEN) 42% Undervaluation?finance.yahoo.com - August 9 at 11:15 AMFibroGen Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 9 at 12:49 AMB of A Securities Downgrades FibroGen (FGEN)msn.com - August 8 at 7:49 PMExpert Ratings for FibroGenmarkets.businessinsider.com - August 8 at 2:49 PMFibroGen Q2 2023 Earnings Previewseekingalpha.com - August 8 at 9:48 AMFibroGen (FGEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimatesfinance.yahoo.com - August 8 at 9:48 AMFibroGen, Inc. (NASDAQ:FGEN) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 8 at 9:48 AMFibroGen (NASDAQ:FGEN) Downgraded to Underperform at Bank of Americamarketbeat.com - August 8 at 7:14 AMJump Financial LLC Buys Shares of 54,174 FibroGen, Inc. (NASDAQ:FGEN)marketbeat.com - August 3 at 5:38 AMSan FranciscoBusiness Timesbizjournals.com - July 31 at 4:08 PMIntercontinental Wealth Advisors LLC Sells 95,650 Shares of FibroGen, Inc. (NASDAQ:FGEN)marketbeat.com - July 29 at 12:31 AMFibroGen, Inc. (NASDAQ:FGEN) Given Average Recommendation of "Reduce" by Brokeragesmarketbeat.com - July 28 at 3:49 AMFibroGen CEO resigns after back-to-back drug study failures, job cutsfinance.yahoo.com - July 25 at 3:44 PMFibroGen, Inc.: FibroGen Announces Leadership Transitionfinanznachrichten.de - July 25 at 10:43 AMFibroGen Announces Leadership Transitionfinance.yahoo.com - July 25 at 10:43 AMFibroGen to Report Second Quarter 2023 Financial Resultsfinance.yahoo.com - July 24 at 8:25 AMState of New Jersey Common Pension Fund D Sells 60,739 Shares of FibroGen, Inc. (NASDAQ:FGEN)marketbeat.com - July 23 at 4:33 AMSF biotech company FibroGen laying off nearly a third of its workersmsn.com - July 20 at 8:49 AMPioneering Mission Bay biotech company Fibrogen to cut more than 100 jobsbizjournals.com - July 19 at 12:27 PMFibroGen (FGEN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?finance.yahoo.com - July 14 at 1:07 PMDown -83.78% in 4 Weeks, Here's Why FibroGen (FGEN) Looks Ripe for a Turnaroundfinance.yahoo.com - July 11 at 3:36 PMAllspring Global Investments Holdings LLC Grows Stock Holdings in FibroGen, Inc. (NASDAQ:FGEN)marketbeat.com - July 10 at 4:20 AMFibroGen (FGEN) Price Target Decreased by 67.57% to 8.16msn.com - July 6 at 3:32 PMDown 80% in 1 Day, Is There Any Hope for FibroGen Stock?finance.yahoo.com - July 1 at 9:10 AM1,344,583 Shares in FibroGen, Inc. (NASDAQ:FGEN) Bought by Assenagon Asset Management S.A.marketbeat.com - June 30 at 6:30 AM Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address FGEN Media Mentions By Week FGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FGEN News Sentiment▼-0.370.52▲Average Medical News Sentiment FGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FGEN Articles This Week▼32▲FGEN Articles Average Week Get FibroGen News Delivered to You Automatically Sign up to receive the latest news and ratings for FGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Lantern Pharma News Today Longeveron News Today FSD Pharma News Today Celularity News Today Hookipa Pharma News Today HCW Biologics News Today Adicet Bio News Today Assembly Biosciences News Today Aeglea BioTherapeutics News Today MEI Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:FGEN) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.